Literature DB >> 10350910

From toy to tool: the development of immersive virtual reality environments for psychotherapy of specific phobias.

A H Bullinger1, A Roessler, F Mueller-Spahn.   

Abstract

Virtual Reality (VR) entered the mental health field some years ago. While the technology itself has been available for more than ten years now, there is still a certain amount of uncertainty among researchers and users as to whether VR will one day fulfill all it's promises. In this chapter we are giving an overview of the implementation of the technology in our mental health research facility in Basel, Switzerland. The development of two applications for use with claustrophobic and acrophobic patients perspectively serves just as an example within this context. Some may say, the chapter is too much based on technical considerations. Strictly speaking, VR is pure technology, even knowing that this special form of technology has sensory, psychological and even philosophical implications not known from other human computer interfaces so far. As far as we are concerned, the development of the technology for use within the mental health sector has merely just begun. As today's mostly used immersive output devices (Head-mounted Displays, shutter glasses) do not have a satisfactory resolution, do restrict movements and prevent multi-user-capabilities, there will be a soar of mental health applications the day some or at least the most important of these obstacles have been overcome.

Entities:  

Mesh:

Year:  1998        PMID: 10350910

Source DB:  PubMed          Journal:  Stud Health Technol Inform        ISSN: 0926-9630


  2 in total

1.  Using the bedside wellness system during chemotherapy decreases fatigue and emesis in cancer patients.

Authors:  H Oyama; M Kaneda; N Katsumata; T Akechi; M Ohsuga
Journal:  J Med Syst       Date:  2000-06       Impact factor: 4.460

2.  The impact of pre-existing anxiety on affective and cognitive processing of a Virtual Reality analogue trauma.

Authors:  Tina Schweizer; Julian Schmitz; Laura Plempe; Dali Sun; Christian Becker-Asano; Rainer Leonhart; Brunna Tuschen-Caffier
Journal:  PLoS One       Date:  2017-12-29       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.